Robyn Temple-Smolkin

Dr. Robyn Temple-Smolkin is the Director of Clinical and Scientific Affairs at Association for Molecular Pathology (AMP). In this role, Robyn is responsible for AMP’s Innovation and Improved Patient Care strategic area, which includes clinical practice guidelines development, scientific and clinical collaborations with other organizations, and other scientific projects. Robyn’s staff group works with AMP’s Clinical Practice Committee, Publications Committee, and five scientific subdivisions – Informatics, Solid Tumors, Genetics, Infectious Disease, and Hematopathology. Robyn has a B.A. in Biology from State University of New York at Geneseo, NY, a Ph.D. in Molecular & Cellular Biology from State University of New York Health Science Center at Brooklyn, NY, and a M.B.A. from Regis University in Denver, CO. Robyn’s background includes molecular diagnostics and pathology, clinical laboratory compliance, process and quality management, and business development. Prior to joining AMP staff, Robyn obtained multiple clinical certifications to include board-certification as a High Complexity Laboratory Director in Molecular Diagnostics (ABB). After fellowship in transplant immunogenetics at the University of Pittsburgh Medical Center, Robyn was a Clinical Molecular Diagnostics Specialist at Shodair Children’s Hospital Medical Genetics Department in Helena, MT where she developed and implemented a clinical pharmacogenetic testing program. She cofounded and served as Director of Laboratory Operations of Big Sky Diagnostic Labs, a CAP-accredited CLIA-licensed independent molecular pathology laboratory focused on women’s health and infectious disease. Also an AMP member for many years, Robyn previously served as a volunteer on both the AMP Membership and Professional Development (Membership Affairs) and Nominating Committees.